Alnylam Pharmaceuticals
ALNY
#667
Rank
C$52.85 B
Marketcap
C$395.88
Share price
-3.22%
Change (1 day)
-5.67%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company